A Study to Determine the Best Dose of Antivirals in Patients With Both TB and HIV (OPTI-NNRTI).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Efavirenz; Nevirapine
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms OPTI-NNRTI
- 22 Jul 2011 Biomarkers information updated
- 21 Jul 2011 Actual initiation date July 2007 added as reported by ClinicalTrials.gov.
- 21 Jul 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.